In today’s recent session, 0.68 million shares of the P3 Health Partners Inc (NASDAQ:PIII) have been traded, and its beta is 0.98. Most recently the company’s share price was $0.20, and it changed around -$0.01 or -0.49% from the last close, which brings the market valuation of the company to $73.56M. PIII at last check was trading at a discount to its 52-week high of $1.35, offering almost -575.0% off that amount. The share price’s 52-week low was $0.18, which indicates that the recent value has risen by an impressive 10.0% since then. We note from P3 Health Partners Inc’s average daily trading volume that its 10-day average is 10.2 million shares, with the 3-month average coming to 2.10 million.
P3 Health Partners Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended PIII as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. P3 Health Partners Inc is expected to report earnings per share of 0 for the current quarter.
P3 Health Partners Inc (NASDAQ:PIII) trade information
Instantly PIII has been showing red trend so far today with a performance of -0.49% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2900 on recent trading dayincreased the stock’s daily price by 31.03%. The company’s shares are currently down -8.85% year-to-date, but still down -4.61% over the last five days. On the other hand, P3 Health Partners Inc (NASDAQ:PIII) is 5.40% up in the 30-day period. We can see from the shorts that 0.96 million shares have been sold at a short interest cover period of 1.21 day(s).
P3 Health Partners Inc (PIII) estimates and forecasts
P3 Health Partners Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -62.89 percent over the past six months and at a -6.35% annual growth rate that is well below the industry average of 24.40%. The year-over-year growth rate is expected to be 19.13%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 378.88M in revenue for the current quarter. 2 analysts expect P3 Health Partners Inc to make 407.15M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 346.86M and 388.49M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 9.23%. Forecasts for the next quarter put sales growth at 4.80%.
PIII Dividends
P3 Health Partners Inc’s next quarterly earnings report is expected to be released in February.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 23.20% of P3 Health Partners Inc shares, and 24.99% of them are in the hands of institutional investors. The stock currently has a share float of 32.53%. P3 Health Partners Inc stock is held by 69.0 institutions, with ALYESKA INVESTMENT GROUP, L.P. being the largest institutional investor. By 2024-06-30, it held 13.4152% of the shares, which is about 15.95 million shares worth $7.18 million.
ARMISTICE CAPITAL, LLC, with 6.645% or 7.9 million shares worth $3.56 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 1.45 shares worth $0.29 million, making up 0.89% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 473.5 shares worth around $95883.0, which represents about 0.29% of the total shares outstanding.
